Has Reza Farid, MD received payments from drug or device companies?

Yes. Drug and device makers reported $37,479 in general payments to Reza Farid, MD across 117 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Reza Farid, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Reza Farid, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Reza Farid, MD

Physical Medicine & Rehabilitation · Columbia, MONPI 1528097722

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Medtronic at 41.2% of the total. Reporting peaked in 2019 at $24,217 and has fallen 98.5% since, to $366 in 2025. Among physical medicine & rehabilitation clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,479in general payments, 2019–2025

Across 117 payments — averaging $320.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$15K
Piramal Critical Care$11K
Flowonix Medical Incorporated$4K
Saol Therapeutics Inc.$2K
Pacira Pharmaceuticals Incorporated$1K
Ipsen Pharma SAS$1K
plus $2K from 7 others

$2,531in research payments, 2019–2025

Across 4 payments — averaging $632.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Merz North America, Inc.$3K

What the payments were for

Consulting fees$7,09219%
Speaking & faculty fees$20,46455%
Travel & lodging$6,49217%
Food & beverage$3,4319%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	37	$15,455
Piramal Critical Care	23	$11,319
Flowonix Medical Incorporated	1	$4,379
Saol Therapeutics Inc.	5	$2,037
Pacira Pharmaceuticals Incorporated	10	$1,349
Ipsen Pharma SAS	2	$1,254
Merz North America, Inc.	9	$692
AbbVie(2 entities)	7	$300
Ipsen Biopharmaceuticals, Inc	12	$271
Merz Pharmaceuticals, LLC	7	$241
Radius Health, Inc.	1	$77
Biogen	2	$56
Sarepta Therapeutics, Inc.	1	$50

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,479 in reported general payments places this provider in the 95th percentile of 182 physical medicine & rehabilitation providers in Missouri.

See all physical medicine & rehabilitation providers in Missouri →

Medicare billing

Part B allowed, 2024

$58,104

Medicare patients

224

Services billed

829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Baclofen	248	$5,921
Midodrine Hcl	31	$3,175
Dantrolene Sodium	13	$2,322
Morphine Sulfate ErMorphine Sulfate	45	$1,846
Tizanidine Hcl	97	$1,262
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	34	$1,164
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	23	$1,013
Lidocaine	23	$939
Gabapentin	44	$910
Ondansetron OdtOndansetron	11	$803
Diazepam	70	$449
Cyproheptadine Hcl	35	$403
Armodafinil	11	$403
Bumetanide	11	$371
Testosterone Cypionate	29	$345

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Columbia

Joseph BurrisColumbia$75K
Jane EmersonColumbia$44K
Vovanti JonesColumbia$9K
Rachael BrashearsColumbia$7K
Hannah FarmerColumbia$4K
John AlmColumbia$3K
Nicholas MadafferColumbia$3K
Mark DrymalskiColumbia$992
Megan ClarkColumbia$564
Kevin ThomasColumbia$399

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →